| Product Code: ETC6749982 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China import shipments of paracetamol IV in 2024 continued to be dominated by top exporting countries such as Puerto Rico, Metropolitan France, Germany, Spain, and Italy. The market concentration, as measured by the HHI index, remained high, indicating a relatively concentrated market. However, there was a decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -2.06%, with a significant drop in the growth rate from 2023 to 2024 at -26.63%. These figures suggest a challenging market environment for paracetamol IV imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Paracetamol IV Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Paracetamol IV Market Revenues & Volume, 2021 & 2031F |
3.3 China Paracetamol IV Market - Industry Life Cycle |
3.4 China Paracetamol IV Market - Porter's Five Forces |
3.5 China Paracetamol IV Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Paracetamol IV Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Paracetamol IV Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 China Paracetamol IV Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring pain management |
4.2.2 Growing elderly population in China |
4.2.3 Rising healthcare infrastructure and investments in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Competition from alternative pain management therapies |
4.3.3 Potential side effects and safety concerns associated with paracetamol IV usage |
5 China Paracetamol IV Market Trends |
6 China Paracetamol IV Market, By Types |
6.1 China Paracetamol IV Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Paracetamol IV Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Paracetamol IV Market Revenues & Volume, By Pain, 2021- 2031F |
6.1.4 China Paracetamol IV Market Revenues & Volume, By Pyrexia (Fever), 2021- 2031F |
6.2 China Paracetamol IV Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Paracetamol IV Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.3 China Paracetamol IV Market Revenues & Volume, By Non-surgical, 2021- 2031F |
6.3 China Paracetamol IV Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 China Paracetamol IV Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Paracetamol IV Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 China Paracetamol IV Market Revenues & Volume, By Others, 2021- 2031F |
7 China Paracetamol IV Market Import-Export Trade Statistics |
7.1 China Paracetamol IV Market Export to Major Countries |
7.2 China Paracetamol IV Market Imports from Major Countries |
8 China Paracetamol IV Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities adopting paracetamol IV in their treatment protocols |
8.2 Average prescription rate of paracetamol IV by healthcare professionals |
8.3 Patient satisfaction and feedback on the effectiveness of paracetamol IV treatment |
9 China Paracetamol IV Market - Opportunity Assessment |
9.1 China Paracetamol IV Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Paracetamol IV Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Paracetamol IV Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 China Paracetamol IV Market - Competitive Landscape |
10.1 China Paracetamol IV Market Revenue Share, By Companies, 2024 |
10.2 China Paracetamol IV Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |